Related Experiment Video
Updated: Feb 17, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Between-trial heterogeneity in meta-analyses may be partially explained by reported design characteristics
Kirsty M Rhodes1, Rebecca M Turner2, Jelena Savović3
1MRC Biostatistics Unit, School of Clinical Medicine, Cambridge Institute of Public Health, University of Cambridge, Forvie Site, Robinson Way, Cambridge Biomedical Campus, Cambridge CB2 0SR, UK.
Risk of bias in Cochrane reviews may influence between-trial heterogeneity. While some bias aspects like sequence generation and blinding might increase heterogeneity, allocation concealment appears to reduce it, though estimates are imprecise.
Area of Science:
- Biostatistics
- Evidence Synthesis
- Clinical Trial Methodology
Background:
- Risk of bias assessments in systematic reviews, particularly Cochrane reviews, are crucial for evaluating study quality.
- Between-trial heterogeneity is a key concern in meta-analysis, potentially impacting the reliability of pooled results.
- Understanding the relationship between specific risk of bias domains and heterogeneity is essential for improving evidence synthesis.
Purpose of the Study:
- To investigate the association between risk of bias judgments (sequence generation, allocation concealment, blinding) in Cochrane reviews and between-trial heterogeneity.
- To estimate the extent to which heterogeneity can be explained by these specific risk of bias characteristics.
- To explore the potential impact of adjusting for bias on meta-analysis accuracy.
Main Methods:
- Bayesian hierarchical models were employed to analyze binary data from 117 meta-analyses.
- The ratio (λ) of heterogeneity change for trials with high/unclear risk of bias versus low risk was estimated.
- Proportion of heterogeneity explained by specific design characteristics was calculated.
Main Results:
- Heterogeneity variances increased with high/unclear risk of bias for sequence generation (λˆ 1.14) and blinding (λˆ 1.74).
- Trials with high/unclear risk of bias for allocation concealment showed reduced heterogeneity (λˆ 0.75).
- A median of 37% of heterogeneity variance was potentially explained by these bias domains; however, all confidence intervals were wide and included the null.
Conclusions:
- Imprecise estimates limit definitive conclusions, but findings suggest reported design characteristics may partially explain between-trial heterogeneity.
- Adjusting for risk of bias could potentially enhance the accuracy of meta-analysis results.
- Further research with more precise estimates is warranted to confirm these associations.
More Related Videos
Related Concept Videos
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Group Design
Study Design in Statistics
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...

